Condition: Steroid-refractory Acute Graft-versus-host Disease · Sponsor: medac GmbH
The primary purpose of this trial is to demonstrate the superiority of MC0518 compared to the first used best available therapy (BAT) with respect to overall response rate (ORR) at Day 28 and/or overall survival (OS) until Visit Month 24 in adult and adolescent subjects with steroid-refractory acute graft-versus-host disease (SR-aGvHD).
This description comes directly from the study's public registry record.
Clinical Trial Information · +49 40103 8006-0 · ClinicalTrialInformation@medac.de
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud | Amiens, France | Recruiting |
| CHU Jean Minjoz | Besançon, France | Recruiting |
| Hopital Michallon | Grenoble, France | Recruiting |
| CHRU Lille- Hopital Claude Huriez | Lille, France | Recruiting |
| CHU de Nantes - Hotel Dieu | Nantes, France | Recruiting |
| CHU de Nice Hopital Archet 1 | Nice, France | Recruiting |
| Centre Hospitalier Lyon Sud Pavillon Marcel Berard 1G | Pierre-Bénite, France | Recruiting |
| Centre Hospitalier Universitaire CHU de Toulouse | Toulouse, France | Recruiting |
| Hopitaux De Brabois | Vandœuvre-lès-Nancy, France | Recruiting |
| Klinikum rechts der Isar | Munich, Bavaria, Germany | Recruiting |
| Universitaetsklinikum Wuerzburg - Medizinische Klinik und Poliklinik II - Zentrum fuer Allogene Blutstammzelltransplantation | Würzburg, Bavaria, Germany | Recruiting |
| Klinikum der Johann Wolfgang Goethe-Universitaet - Frankfurt am Main | Frankfurt am Main, Hesse, Germany | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04629833